Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase 1 6Phase 3 4Phase NA 2Phase 1/2 2Phase 2/3 1

Status

Withdrawn 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 4Gynecologic 2Genitourinary 2Head & Neck 1Gastrointestinal 1

Conditions

Testicular Neoplasms 1Seminoma 1Infiltrating Bladder Urothelial Carcinoma 1

Interventions

Radiosurgery 73Magnetic Resonance Spectroscopy 48Standard of Care 41Radiotherapy 36Exercise 36Blood Specimen Collection 28Early Intervention, Educational 26Surveys and Questionnaires 24Multiparametric Magnetic Resonance Imaging 22Magnetic Resonance Imaging 21Brachytherapy 21Androgen Antagonists 20Methods 19Therapeutics 18Radiotherapy, Intensity-Modulated 18Interviews as Topic 18Cystectomy 16Educational Status 15Biopsy 15Psychiatric Rehabilitation 14Practice Guidelines as Topic 14Diet Therapy 14Sunitinib 12Specimen Handling 12Resistance Training 12gallium 68 PSMA-11 11Radiation 11Watchful Waiting 9Surgical Procedures, Operative 9Proton Therapy 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Platinum × Genitourinary × Clear all
NCT07498959 2026-03-27

TESTIGO

Sahlgrenska University Hospital

Phase NA Recruiting
160 enrolled
Genitourinary

Testicular Neoplasms, Seminoma

NCT02944357 2017-11-17

Gemcitabine Hydrochloride, Cisplatin, and AGS-003-BLD in Treating Patients With Muscle-Invasive Bladder Cancer Undergoing Surgery

Mayo Clinic

Phase NA Withdrawn
Genitourinary

Infiltrating Bladder Urothelial Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡